21-12-2017 | Flash glucose monitoring | Gallery
Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial
This slide set outlines the results of an open-label trial suggesting that the use of flash glucose-sensing technology results in similar changes in glycated hemoglobin over 6 months compared with standard self-monitoring among insulin-treated patients with type 2 diabetes.
Read the full-text article here
Funded by an educational grant from Abbott Diabetes Care
Advertisement